These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27612807)

  • 41. Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier.
    Da Ros M; De Gregorio V; Iorio AL; Giunti L; Guidi M; de Martino M; Genitori L; Sardi I
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanobubbles: a promising efficient tool for therapeutic delivery.
    Cavalli R; Soster M; Argenziano M
    Ther Deliv; 2016; 7(2):117-38. PubMed ID: 26769397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A local combination therapy to inhibit GBM recurrence.
    Schwendeman SP
    J Control Release; 2019 Sep; 309():339-340. PubMed ID: 31437469
    [No Abstract]   [Full Text] [Related]  

  • 44. Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies.
    Karlsson J; Luly KM; Tzeng SY; Green JJ
    Adv Drug Deliv Rev; 2021 Dec; 179():113999. PubMed ID: 34715258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies.
    Dhami NK; Pandey RS; Jain UK; Chandra R; Madan J
    J Microencapsul; 2014; 31(7):685-93. PubMed ID: 24963955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice.
    Ranganath SH; Fu Y; Arifin DY; Kee I; Zheng L; Lee HS; Chow PK; Wang CH
    Biomaterials; 2010 Jul; 31(19):5199-207. PubMed ID: 20350766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo.
    Zhan C; Wei X; Qian J; Feng L; Zhu J; Lu W
    J Control Release; 2012 Jun; 160(3):630-6. PubMed ID: 22410115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series.
    Shin BJ; Burkhardt JK; Riina HA; Boockvar JA
    Neurosurg Clin N Am; 2012 Apr; 23(2):323-9, ix-x. PubMed ID: 22440875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytotoxic and apoptotic effects of bortezomib and gefitinib compared to alkylating agents on human glioblastoma cells.
    Pédeboscq S; L'Azou B; Passagne I; De Giorgi F; Ichas F; Pometan JP; Cambar J
    J Exp Ther Oncol; 2008; 7(2):99-111. PubMed ID: 18771084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of carbonic anhydrase IX in glioblastoma multiforme.
    Amiri A; Le PU; Moquin A; Machkalyan G; Petrecca K; Gillard JW; Yoganathan N; Maysinger D
    Eur J Pharm Biopharm; 2016 Dec; 109():81-92. PubMed ID: 27702686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment.
    Gao H; Yang Z; Cao S; Xiong Y; Zhang S; Pang Z; Jiang X
    Biomaterials; 2014 Feb; 35(7):2374-82. PubMed ID: 24342723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
    Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
    Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proapoptotic miltefosine nanovesicles show synergism with paclitaxel: Implications for glioblastoma multiforme therapy.
    Thakur A; Joshi N; Shanmugam T; Banerjee R
    Cancer Lett; 2013 Jul; 334(2):274-83. PubMed ID: 22935677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles.
    Bouras A; Kaluzova M; Hadjipanayis CG
    J Neurooncol; 2015 Aug; 124(1):13-22. PubMed ID: 25981803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N; Tong YW; Yang YY
    Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y; Pan L; Jiang M; Li D; Jin L
    Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of glioma by cisplatin-loaded nanogels conjugated with monoclonal antibodies against Cx43 and BSAT1.
    Baklaushev VP; Nukolova NN; Khalansky AS; Gurina OI; Yusubalieva GM; Grinenko NP; Gubskiy IL; Melnikov PA; Kardashova KSh; Kabanov AV; Chekhonin VP
    Drug Deliv; 2015 May; 22(3):276-85. PubMed ID: 24437962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraarterial drug delivery for glioblastoma mutiforme: Will the phoenix rise again?
    Joshi S; Ellis JA; Ornstein E; Bruce JN
    J Neurooncol; 2015 Sep; 124(3):333-43. PubMed ID: 26108656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ApoE enhances nanodisk-mediated curcumin delivery to glioblastoma multiforme cells.
    Ghosh M; Ryan RO
    Nanomedicine (Lond); 2014 May; 9(6):763-71. PubMed ID: 23879635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of Biological Activities in Glioblastoma Mediated by Curcumin.
    Trotta T; Panaro MA; Prifti E; Porro C
    Nutr Cancer; 2019; 71(8):1241-1253. PubMed ID: 31007066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.